Endoglin is overexpressed after arterial injury and is required for transforming growth factor-β-induced inhibition of smooth muscle cell migration

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 12, 2000, Pages 2546-2552

  Ma, Xiaoli ^a   Labinaz, Marino ^a   Goldstein, Jason ^a   Miller, Harvey ^a   Keon, Wilbert J ^a   Letarte, Michelle ^b   O'Brien, Edward ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Endoglin; Endothelial cells; Receptors; Smooth muscle cells; Transforming growth factor

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ENDOGLIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

ADVENTITIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTERY INJURY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BALLOON CATHETER; CELL MIGRATION; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; ENDARTERECTOMY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; IN VITRO STUDY; INTERNAL MAMMARY ARTERY; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; SWINE;

EID: 0033673419     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.12.2546     Document Type: Article

References (53)

1. Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions
2. Distinct patterns of transforming growth factor-β isoform and receptor expression in human atherosclerotic lesions: Colocalization implicates TGF-β in fibrofatty lesion development
3. βig-h3, a transforming growth factor-β-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions
4. Expression of transforming growth factor-β1 and urokinase-type plasminogen activator genes during arterial repair in the pig
5. Transforming growth factor-beta1 expression and myofibroblast formation during arterial repair
6. Coronary atherogenesis and restenosis: The role of βig-h3, a TGF-β-inducible molecule in these special forms of wound healing
7. In vivo effect of TGF-β1: Enhanced intimal thickening by administration of TGF-β1 in rabbit arteries injured with a balloon catheter
8. Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia
9. Production of transforming growth factor beta-1 during repair of arterial injury
10. Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model
11. Mechanism of activation of the TGF-β receptor
12. Effects of transforming growth factor-β1 on human arterial smooth muscle cells in vitro
13. Decreased type II/type I TGF-β receptor ratio in cells derived from human atherosclerotic lesions
14. Endoglin is a component of the transforming growth factor-receptor system in human endothelial cells
15. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-β
16. Endoglin is a component of the functional TGF-β receptor complex of human pre-B leukemic cells
17. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells
18. Identification of distinct epitopes of endoglin, an RGD containing-glycoprotein of endothelial cells, leukemic cells and syncytiotrophoblasts
19. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-β binding protein of endothelial and stromal cells
20. Distribution of endoglin in early human development reveals high levels on endocardial cushion tissue mesenchyme during valve formation
21. Assignment of the human endoglin gene (END) to chromosome 9q34qter
22. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1
23. Hereditary hemorrhagic telangiectasia
24. Mutant endoglin in hereditary hemorrhagic telangiectasia type I is transiently expressed intracellularly and is not a dominant negative
25. Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: Issues in clinical management and review of pathogenic mechanisms
26. A new 180-kDa dermal endothelial cell activation antigen: In vitro and in situ characteristics
27. A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues
28. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: Implications for diagnosis and therapy
29. Expression of endoglin mRNA and protein in human vascular smooth muscle cells
30. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily
31. Endoglin overexpression modulates cellular morphology, migration, and adhesion of mouse fibroblasts
32. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants
33. The relative importance of arterial contracture and neointimal formation in lumenal renarrowing following balloon angioplasty: Insights from a porcine coronary model of single and double balloon injury
34. Adventitial angiogenesis early after coronary angioplasty is accompanied by microvessel regression and arterial renarrowing
35. CD105 (endoglin) cluster report
36. EC2 CD105 Workshop Panel Report
37. Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments
38. Osteopontin is synthesized by macrophage, smooth muscle and endothelial cells in primary and restenotic human coronary atherosclerotic plaques
39. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration
40. Adventitial remodeling after coronary artery injury
41. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries
42. Phenotype modulation in primary cultures of arterial smooth muscle cells: On the role of platelet-derived growth factor
43. Transforming growth factor in tissue fibrosis
44. Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies
45. Hypothesis: Vasa vasorum and neovascularization of human coronary arteries
46. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-β isoforms and their receptors following arterial injury
47. Cell type specificity of the human endoglin promoter
48. Cell-cell interactions in vessel assembly: A model for the fundamentals of vascular remodelling
49. Defective angiogenesis in mice lacking endoglin
50. A murine model of hereditary hemorrhagic telangiectasia
51. Antisense therapy for angioplasty restenosis: Some critical considerations
52. Selection of single-stranded DNA molecules that bind and inhibit human thrombin